Total Payments
$543,333
2024 Payments
$184,908
Companies
32
Transactions
1,040
Medicare Patients
561
Medicare Billing
$88,487
Payment Breakdown by Category
Other$435,749 (80.2%)
Travel$53,495 (9.8%)
Consulting$32,067 (5.9%)
Food & Beverage$21,939 (4.0%)
Education$83.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $430,799 | 213 | 79.3% |
| Travel and Lodging | $53,495 | 241 | 9.8% |
| Consulting Fee | $32,067 | 13 | 5.9% |
| Food and Beverage | $21,939 | 570 | 4.0% |
| Honoraria | $4,950 | 2 | 0.9% |
| Education | $83.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $348,622 | 370 | $0 (2024) |
| Alkermes, Inc. | $96,789 | 225 | $0 (2024) |
| ABBVIE INC. | $57,974 | 180 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $25,578 | 86 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $5,340 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,188 | 9 | $0 (2024) |
| Axsome Therapeutics, Inc. | $1,781 | 12 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,463 | 2 | $0 (2024) |
| Validus Pharmaceuticals LLC | $507.28 | 3 | $0 (2024) |
| Tris Pharma Inc | $395.27 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $184,908 | 394 | Neurocrine Biosciences, Inc. ($99,759) |
| 2023 | $163,486 | 307 | Neurocrine Biosciences, Inc. ($90,003) |
| 2022 | $143,187 | 244 | Neurocrine Biosciences, Inc. ($117,027) |
| 2021 | $51,752 | 95 | Neurocrine Biosciences, Inc. ($41,833) |
All Payment Transactions
1,040 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $40.90 | General |
| 12/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: CNS | ||||||
| 12/19/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $188.94 | General |
| Category: CNS | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,563.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $696.96 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $351.31 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $68.31 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: CNS | ||||||
| 12/12/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: CNS | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $104.27 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ADHD | ||||||
| 12/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: CNS | ||||||
| 12/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: CNS | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $275.00 | General |
| 12/03/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/26/2024 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.14 | General |
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 83 | 191 | $45,510 | $13,150 |
| 2022 | 3 | 90 | 186 | $44,045 | $12,676 |
| 2021 | 3 | 145 | 359 | $74,470 | $25,650 |
| 2020 | 6 | 243 | 762 | $112,934 | $37,011 |
Total Patients
561
Total Services
1,498
Medicare Billing
$88,487
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 150 | $36,000 | $9,922 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 24 | $6,960 | $2,608 | 37.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 17 | $2,550 | $619.21 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 145 | $34,800 | $9,574 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 23 | $6,545 | $2,269 | 34.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 12 | 18 | $2,700 | $833.31 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 313 | $64,720 | $22,216 | 34.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 27 | $6,900 | $2,688 | 39.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 17 | 19 | $2,850 | $746.51 | 26.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 519 | $93,095 | $30,077 | 32.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 44 | 69 | $9,500 | $2,843 | 29.9% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Office | 2020 | 17 | 17 | $4,624 | $1,569 | 33.9% |
| 80305 | Testing for presence of drug | Office | 2020 | 17 | 111 | $2,220 | $1,392 | 62.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 20 | $2,915 | $923.11 | 31.7% |
| 90785 | Interactive complexity | Office | 2020 | 19 | 26 | $580.00 | $207.17 | 35.7% |
About Jo Hughes, PA-C
Jo Hughes, PA-C is a Physician Assistant healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1265663371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jo Hughes, PA-C has received a total of $543,333 in payments from pharmaceutical and medical device companies, with $184,908 received in 2024. These payments were reported across 1,040 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($430,799).
As a Medicare-enrolled provider, Hughes has provided services to 561 Medicare beneficiaries, totaling 1,498 services with total Medicare billing of $88,487. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Greensboro, NC
- Active Since 08/06/2009
- Last Updated 05/19/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1265663371
Products in Payments
- INGREZZA (Drug) $348,622
- LYBALVI (Drug) $92,294
- VRAYLAR (Drug) $57,699
- Qelbree (Drug) $21,669
- ARISTADA (Drug) $4,466
- UZEDY (Drug) $3,891
- QELBREE (Drug) $3,870
- Auvelity (Drug) $1,598
- CAPLYTA (Drug) $532.04
- Equetro (Drug) $507.28
- SPRAVATO (Drug) $279.31
- Dyanavel XR (Drug) $250.43
- JORNAY PM (Drug) $229.59
- Sunosi (Drug) $182.44
- REXULTI (Drug) $171.79
- AUSTEDO (Drug) $157.18
- HETLIOZ (Drug) $151.34
- FANAPT (Drug) $137.73
- Azstarys (Drug) $136.47
- Quillichew ER (Drug) $123.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Greensboro
Kayla Mckenzie, Pa-C, PA-C
Physician Assistant — Payments: $50,712
Physician Assistant $50,712
Ms. Deanna Michelle Lalama, Pa-C, PA-C
Physician Assistant — Payments: $10,648
Physician Assistant $10,648
Kara Probst
Physician Assistant — Payments: $10,208
Physician Assistant $10,208
Taylor Dale, Pa-C, PA-C
Physician Assistant — Payments: $8,362
Physician Assistant $8,362
Karen Teague Clark, Pa-C, PA-C
Physician Assistant — Payments: $6,071
Physician Assistant $6,071
Uchenna Nwoko, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $4,941
Physician Assistant $4,941